Fluoroscopy and Mobile C-arms Market to Show Poor Growth Despite Interventional Radiology Boosts

Transparency Market Research has released a new market study titled "Fluoroscopy and Mobile C-arms Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" The global fluoroscopy and mobile C-arms market had reached a value of US$1.69 billion in 2012 and is estimated to be worth US$2.08 billion in 2019, expanding at 3% CAGR from 2013 to 2019.

Fluoroscopy and mobile C-arms devices are used to analyze parts of the body and work in a fashion similar to X-rays. The only difference is that fluoroscopy and mobile C-arms devices provide live images of the anatomy, making it more useful during surgical procedures. These equipment are mainly utilized in orthopedic operations such as arthrography and barium X-rays, in minimally invasive imaging during lumbar puncture, cardiac catheterization, and biopsies, and for the placement of intravenous catheters into veins and arteries.

The fluoroscopy and mobile C-arms market is likely to register rapid growth due to rising demand for interventional radiology operations. In addition to this, growing number of orthopedic surgeries owing to sport injuries and geriatric population, developments in technology, and increase in number of hospitals are some other factors that are adding up towards the development of the global fluoroscopy and mobile C-arms market.

We are currently offering a flat 15% discount on all purchases until end of the March 2015:- http://www.transparencymarketresearch.com/fluoroscopy-mobile-c-arm.html

The market for fluoroscopy and mobile C-arms devices worldwide is evaluated on the basis of product type and region.

Based on types, in 2012, fluoroscopy devices accounted for the largest share of the fluoroscopy and mobile C-arms devices industry in terms of revenue. However, the mobile C-arms section is dominating the fluoroscopy and mobile C-arms market at present in terms of volume. Mobile C-arms are further classified into mini C-arms and full size C-arms. It is anticipated that the full size C-arms segment will develop at a faster pace in the global fluoroscopy and mobile C-arms industry during 2013 to 2019. The development in full size C-arms devices market is credited to technical advancements in the field and multiple applications.

Get Sample Report Copy with TOC and Market Research : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1485

Regionally, North America led the global fluoroscopy and mobile C-arms market in 2012, both in terms of volume and value, due to the increasing awareness about medical imaging equipment, financial stability to purchase expensive devices, adoption of new and innovative products, and growing infrastructure investment to support medical and healthcare development. On the other hand, the fluoroscopy and mobile C-arms market in Asia Pacific is likely to develop at the highest compound annual growth rate in diagnosis and interventional radiology procedures.

The global fluoroscopy and mobile C-arms market is segmented into the following categories:

Fluoroscopy and Mobile C-arms market, by Product Type

• Fluoroscopy
• Mobile C-arms
• Full Size C- Arms
• Mini C-arms

Fluoroscopy and Mobile C-arms Market, by Geography

• North America
• Fluoroscopy
• Mobile C-arms
• Europe
• Fluoroscopy
• Mobile C-arms
• Asia-Pacific
• Fluoroscopy
• Mobile C-arms
• Rest of the World (RoW)
• Fluoroscopy
• Mobile C-arms

Browse Full Press Release of This Report:- http://www.transparencymarketresearch.com/pressrelease/fluoroscopy-mobile-c-arm-market.htm

Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020

According to a new market report published by Transparency Market Research “Surgical Navigation Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020”, the global surgical navigation systems market was valued at USD 218.5 million in 2013 and is expected to grow at a CAGR of 4.5% from 2014 to 2020, to reach an estimated value of USD 295.5 million in 2020.

Surgical navigation systems assist surgeons in reaching the target anatomical position of the patient. Post-operative wound healing takes more time in conventional surgeries than minimally invasive surgeries due to smaller incision. Surgical navigation systems enable minimally invasive surgeries. In addition, surgical navigation systems facilitate reaching precise targeted anatomical site for surgery, more accurate operative procedure and thereby decreasing risk of failure. Thus, adapting surgical navigation systems in practice is beneficial for both patients as well as hospitals. Therefore, market players are implementing various strategies to spread awareness about surgical navigation systems and related benefits which is ultimately resulting in growth of the global surgical navigation systems market.

We are currently offering a flat 15% discount on all purchases until end of the March 2015:- http://www.transparencymarketresearch.com/surgical-navigation-systems-market.html

The global surgical navigation systems market is segmented on the basis of type of products namely, neurosurgical navigation systems, ENT navigation systems and orthopedic navigation systems. Neurosurgeries including spinal surgeries are the most complicated surgeries and thus demand for accuracy is higher in neurosurgeries. Hence, neurosurgical navigation systems accounted for the largest market share in 2013.

High cost of surgical navigation systems is one of the major factor that is restraining the growth of the global surgical navigation systems market. Demand for surgical navigation systems is expected to rise with increased awareness about surgical navigation systems and related benefits. Further, to expand market share, existing players in the surgical navigation systems market are expected to implement strategies such as acquisition of small players, partnering with the competitor and offering long-term contracts to customers in order to maintain relation with end users.

Presently, North America is dominating the global surgical navigation systems market with a share of 40% in 2013. Some of the major factors that are driving the North American surgical navigation systems market towards growth include well-defined regulatory framework, higher rates of implementing regulations in practice that are set by regulatory authorities and highly developed healthcare infrastructure. The Asia-Pacific region is anticipated to have higher growth potential for surgical navigation systems market due to rapidly developing healthcare infrastructure on the grounds of swiftly rising medical tourism industry in the region. Some of the key market players contributing to surgical navigation systems industry include BrainLAB AG, Aesculap Implant Systems (B. Braun Melsungen AG), LLC, GE Healthcare, Medtronic, Inc., Siemens Healthcare Corporation, Stryker Corporation and Zimmer Holdings.

Get Sample Report Copy with TOC and Market Research :- http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2646

The global computer aided detection market is segmented as follows:

Global Surgical Navigation Systems Market, by Product Type

- Neurosurgical Navigation Systems

- ENT Navigation Systems

- Orthopedic Navigation Systems

Global Surgical Navigation Systems Market, by Geography

- North America

- Europe

- Asia-Pacific

- Rest of the World

Browse Full Press Release of This Report:- http://www.transparencymarketresearch.com/pressrelease/surgical-navigation-systems-market.htm

Intrathecal Pumps Market Expected to Reach USD 0.26 Billion Globally in 2020

According to a new market report published by Transparency Market Research “Intrathecal Pumps Market - Global Industry Analysis, Size, Share, Procedures, Growth, Trends and Forecast, 2014 - 2020,” the global intrathecal pumps market was valued at USD 0.19 billion in 2013 and is expected to grow at a CAGR of 4.1% from 2014 to 2020, to reach an estimated value of USD 0.26 billion in 2020.

Intrathecal pumps are implantable infusion devices, miniature in size and are surgically placed under the skin of the abdomen. These intrathecal pumps deliver medication through a small flexible tube called catheter, to the spine. These pumps are capable of delivering precise dose of medication from one or any combination of reservoirs without complex pumping and are generally opted when a patient seeks long term medication and other alternatives are costly or less effective. A drug can be infused over an extended period of time and can be delivered at constant or variable rates by regulating the implantable infusion pump as per physician specifications. The drug reservoir is refilled with the help of an external needle injection via a self-sealing septum in the implantable infusion pump.

We are currently offering a flat 15% discount on all purchases until end of the March 2015:- http://www.transparencymarketresearch.com/intrathecal-pumps-market.html

The global intrathecal pumps market can be categorized into two major applications: pain and spasticity management. Pain management accounts for the largest share in the intrathecal pumps market, followed by spasticity management. It is expected that the global market for pain management will grow at a CAGR of over 4% from 2014 to 2020. According to the data provided by the International Agency for Research on Cancer (IARC), the number of cancer patients in 2012 rose to 14.1 million new cases in 2012 and the number of deaths due to cancer was estimated to be approximately 8.2 million. With such large magnitude of the disease, there is substantial need for infusion systems to treat cancer pain. Hence, the intrathecal pumps market is expected to grow further as more and more drugs demonstrate safety and efficacy.

With technological up gradation, researchers have successfully developed and manufactured infusion pumps that can deliver multiple medications via a single infusion pump such as use of morphine in treating nociceptive pain and bupivacaine in treating neuropathic pain. The use of multiple medications in a single drug reservoir may bring in drug stability issues and a complex dosing challenge with respect to varying concentration and administration rates for each drug. Thus, many more product modifications are still required to assure precise and accurate drug administration with minimal error rates.

Geographically, North America is the dominant regional market for intrathecal pumps with almost half of the market share, followed by Europe accounting for around 30% share due to large patient base suffering from chronic pain. The positive reimbursement scenario for these devices in the U.S. contributed significantly to the growth of the market. The intrathecal pumps market in North America is expected to grow at a CAGR of more than 3.5% during the forecast period from 2014 to 2020.

Emerging nations such as India, China, and Brazil offer immense opportunities for the growth of the intrathecal infusion pumps market. Some major factors responsible are growing economy and strengthening insurance policies. The economic growth in these developing countries is expected to enhance disposable income of the patient population and in turn increase the healthcare expenditures. It has also helped increase healthcare infrastructure investments in several countries which will intensify growth of hospital equipment in most countries. Government of these nations in collaboration with private insurance companies are focusing towards improving healthcare coverage in order to support access to better healthcare facilities.

If safety issues concerned with the devices can be controlled and curbed, the market for implantable infusion pumps is likely to grow exponentially in the future as Medtronic, till its recall in 2013, sold almost 140,000 Synchromed Pumps which were mostly used in pain management. It is estimated that 116 million people in the U.S. suffer from chronic pain, which in many cases is not adequately controlled with pain management drugs, including oral narcotic agents and others. This will create growth opportunity for device manufacturers in terms of sales and revenue. The competition in this market is characterized by market consolidation activities, partnerships and intensive mergers and acquisitions. Intrathecal pumps market is dominated by few major players such as Medtronic, Inc., Codman & Shurtleff, Inc. and Flowonix, Inc. Other players in the intrathecal pumps market are Arrow International, Inc., Tricumed GmbH and Medallion Therapeutics, Inc.

Get Sample Report Copy with TOC and Market Research :- http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1599

The global intrathecal pumps market is segmented as follows:

Intrathecal Pumps Market, by Application

Pain Management

• North America
• U.S.
• Canada
• Europe
• Asia Pacific
• Rest of the World

Spasticity Management

• North America
• U.S.
• Canada
• Europe
• Asia Pacific
• Rest of the World

Browse Full Press Release of This Report:- http://www.transparencymarketresearch.com/pressrelease/intrathecal-pumps-market.htm

Spectrometry Market Expected to Reach USD 19.6 Billion Globally in 2020

According to a new market report published by Transparency Market Research "Spectrometry Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020", the global spectrometry market was valued at USD 12,212.9 million in 2013 and is estimated to reach USD 19,608.7 million by 2020 at a CAGR of 7.2% from 2014 to 2020.

Spectrometry is a scientific technique employed to access properties of light within specific electromagnetic spectrum to identify variety of materials. In the past few decades spectrometry techniques have been resilient enough in providing scientists an informative tool to cater to vast array of applications in various industries. Overall competition in spectrometry market is intense with large conglomerates competing for considerably small application areas and end user segments. Multinational companies account for majority of the revenue share in overall market. The spectrometry market caters to several end user segments such as life sciences, petrochemical, food and safety, forensics among several others. Advanced spectrometry devices allow simultaneous analysis of low concentration analytes in blood samples without any need for sample preparation and other conventional processing techniques such as centrifugation and reagent preparation.

We are currently offering a flat 15% discount on all purchases until end of the March 2015:- http://www.transparencymarketresearch.com/spectrometry-market.html

The global spectrometry market can be studied from two perspectives: by technologies and by application areas. The global spectrometry market by technology can be further broken down into atomic spectrometry, mass spectrometry and molecular spectrometry. The atomic spectrometry segment encompasses atomic absorption spectrometry, X-ray diffraction spectrometry, X-ray fluorescence spectrometry, inductively coupled plasma-atomic emission spectrometer, elemental analyzers and other atomic spectrometers. Atomic spectrometers generally provide information about elemental composition of samples based on the emission of lights that are characteristic of elements present in the sample. The molecular spectrometry market includes nuclear magnetic resonance spectrometry, ultraviolet visible spectrometry, infrared spectrometry, color measurement, near-infrared spectrometry and Raman spectrometry. By 2020, nuclear magnetic resonance (NMR) spectrometry is likely to lead the market in terms of revenues which is estimated to reach approximately USD 1.7 billion worldwide. Sales in molecular spectrometry are majorly contributed by infrared, near-infrared and Raman spectrometry owing to increasing demand for devices in academic and research institutes, security and defense sector especially in economically developed countries. The mass spectrometry segment include variety of products such as gas chromatography-mass spectrometry(GC-MS), liquid chromatography-mass spectrometry (LC-MS), matrix-assisted laser desorption/ionization-time of flight spectrometry (MALDI-TOF), triple-quadrupole liquid chromatography-mass spectrometry, quadrupole-time of flight liquid chromatography-mass spectrometry (Q-TOF LC/MS), inductively coupled plasma mass spectrometry and others.

Innovation in spectrometry techniques has been a major contributing factor for the growth and demand in past couple of years. Handheld and portable instruments with superior imaging quality have effectively contributed towards onsite analysis of samples which reduces the efforts of carrying heavy and bulky samples to laboratories for analysis. Handheld and portable spectrometry devices have found indispensible application in drug identification, food inspection, environmental application and defense sector. The global spectrometry devices market by application is sub-categorized into pharmaceuticals, biotechnology, industrial chemistry, environmental testing, food and beverages among others. Increasing clinical application of spectrometry device in tissue analysis, toxicology, proteomics and disease marker is effectively contributing towards growth and uptake of global spectrometry market. Stringent regulatory scenario with respect to monitoring of soil and water samples is also contributing towards growth and procurement of spectrometry devices globally. Biotechnology market by 2020 is expected to be the fastest growing application area with a CAGR of 18.4%.

Geographically, the spectrometry market is segmented into four prominent geographies: North America, Europe, Asia-Pacific and Rest of the World. Although market for spectrometry devices in developed economic countries such as the United States and Europe in terms of technological advancements has attained a saturation level yet widening of application areas such as space and aeronautics and defense would continue to contribute towards market growth in these regions. Moreover, funds allocation from government organizations and companies for conducting research and development activities at various universities and private research center level are other prominent drivers for the growth of spectrometer devices. Companies like Thermo Fisher Scientific and Waters Corporation in order to promote academic research by young scientists in mass spectrometry sponsor 2 research awards worth USD 35,000 each to academic scientists. Such activity not only promotes the overall spectrometry market but also encourages research studies to explore and develop novel techniques and application areas pertaining to mass spectrometry development. Apart from this AB SCIEX, an analytical tool manufacturer conducts Young Investigators Grant and Partnerships Award Program to provide special grants to budding researchers and scientists which can be used towards the purchase of selected AB SCIEX MS or LC/MS systems. Asia-Pacific and rest of the World market are among the fastest growing market by 2020 owing to inclination of investment by key players towards these markets primarily due to presence of large untapped customer base and increasing research activities in countries like India, China and other South East Asian countries.

Some of the key players in the global spectrometry market include Thermo Fisher Scientific, Inc., Perkin Elmer, Inc., Agilent Technologies, Inc., Bruker Corporation, Waters Corporation, Shimadzu Corporation, AB Sciex and others.

Get Sample Report Copy with TOC and Market Research :- http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=457

The global spectrometry market is segmented as follow:

Spectrometry Market, by Technology

Atomic Spectrometry

• Atomic Absorption Spectrometry
• X-ray Diffraction Spectrometry
• X-ray Fluorescence Spectrometry
• Elemental Analyzers
• Inductively Coupled Plasma Atomic Emission Spectrometry
• Others
• Molecular Spectrometry

Nuclear Magnetic Resonance Spectrometry

• Ultraviolet Visible Spectrometry
• Infrared Spectrometry
• Color Measurement
• Near Infrared Spectrometry
• Raman Spectrometry
• Others

Mass Spectrometry

• Gas Chromatography-Mass Spectrometry
• Liquid Chromatography-Mass Spectrometry
• Matrix-Assisted Laser Desorption/Ionization-Time of Flight Spectrometry
• Triple-Quadrupole Liquid Chromatography-Mass Spectrometry
• Quadrupole-Time of Flight Liquid Chromatography-Mass Spectrometry
• Inductively Coupled Plasma Mass Spectrometry
• Others

Spectrometry Market, by Application

• Pharmaceuticals
• Biotechnology
• Industrial Chemistry
• Environmental Testing
• Food and Beverages Testing
• Others

Spectrometry Market, by Geography

• North America
• Europe
• Asia-Pacific
• Rest of the World

Browse Full Press Release of This Report:- http://www.transparencymarketresearch.com/pressrelease/spectrometry-market.htm

Computer Aided Detection Market Expected to Reach USD 1.47 Billion Globally in 2020

According to a new market report published by Transparency Market Research “Computer Aided Detection Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020,” the global computer aided detection market was valued at USD 0.72 billion in 2013 and is expected to grow at a CAGR of 10.8% from 2014 to 2020, to reach an estimated value of USD 1.47 billion in 2020.

Computer Aided Detection (CAD) is a technique that can help radiologists precisely interpret images and procure potential findings to avoid erroneous interpretation, thereby enhancing the error free diagnosis of various diseases. Currently, the global CAD market is in early growth stage and is highly reliant on its corresponding imaging modality market dynamics for its market penetration. With the increasing use of CAD software solutions for various diagnostic applications such as oncology, cardiovascular, neurological and musculoskeletal, the market can be described to be highly specific, dynamic and competitive with substantial growth potential.

We are currently offering a flat 15% discount on all purchases until end of the March 2015:- http://www.transparencymarketresearch.com/computer-aided-detection.html

Rising incidence of various types of cancer such as breast, lung, prostate and colorectal cancer is the primary responsible factor for the growth of CAD market. Additionally, advancements in digital imaging techniques, improved efficiencies of CAD solutions, ease of integration of CAD solutions with various imaging equipment and growing awareness among the patients about early detection of cancer have boosted the overall growth of this market. Further, expansion of CAD applications to newer clinical areas, active research and development activities in medical imaging, rapid transition of hospitals to promote automatic workflow integration in their current work environment and rising installation base of CAD solutions in various multispecialty hospitals is further expected to accentuate the growth of this market in coming years. However, certain restraining factors such as lack of adequate clinical data validating the clinical efficacy of CAD solutions in its role of early diagnosis of the disease, disinclination of healthcare professionals in accepting these solutions as a standard imaging tool and premium pricing might hamper the growth of this market. Similarly, unfavorable taxation and lack of favorable reimbursement policies in the European and Asian governments have also negatively impacted the growth of this market.

The CAD market for breast cancer application was estimated to be the largest market with a share of more than 70% in 2013 and is predicted to maintain its leading position until the end of forecast period i.e. 2020. Such dominance is observed mainly due to the increasing number of breast cancer detection applications and lower risk of observational errors by using CAD solutions in combination with mammography. Digital mammography offers significantly better diagnosis in early detection of breast cancer than film mammography. Additionally, favorable reimbursement scenario for breast cancer CAD solutions in developed nations and its well-established identity as a supplement tool in diagnosis of breast cancer is further aiding the growth of this market. Simultaneously, in terms of growth rate, the CAD market for lung cancer application is forecast to grow at the fastest growth rate from 2014 to 2020. The faster growth rate of lung cancer CAD market has been attributed to the increasing number of regulatory approvals for various lung cancer detection CAD solutions and rising incidence of the disease.

Geographically the North American market accounted for the largest share of overall CAD market in 2013. However, Asia-Pacific countries namely Japan, South Korea, Malaysia, Australia, Thailand, India and China are witnessing fast growth and are predicted to emerge as opportunistic markets in the near future owing to growing awareness among patients, education on the importance of early screening by various government agencies and NGOs and increased disposable income in these nations. Additionally, growth in medical tourism in this region is also boosting the adoption of CAD solutions in various multispecialty hospitals.

The major players of this market include Hologic, Inc. iCAD, Inc., Agfa-Gevaert N.V., EDDA Technology, Inc., Fujifilm Medical Systems, Inc., GE Healthcare Ltd., Hitachi Medical Corporation, Invivo Corporation, VuCOMP, McKesson Corporation, Philips Healthcare, Siemens Healthcare, etc.

Get Sample Report Copy with TOC and Market Research :- http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1442

The global computer aided detection market is segmented as follows:

Computer Aided Detection Market, by Application

• Breast Cancer
• Mammography
• Magnetic Resonance Imaging
• Ultrasound Imaging
• Tomosynthesis
• Nuclear Imaging
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Liver Cancer
• Boner Cancer
• Neurological/Musculoskeletal/Cardiovascular

Computer Aided Detection Market, by Imaging Modalities

• X-Ray Imaging
• Computed Tomography
• Ultrasound Imaging
• Magnetic Resonance Imaging
• Nuclear Medicine Imaging
• Others

Computer Aided Detection Market, by Geography

• North America
• Europe
• Asia Pacific
• Rest of the World (RoW)

Browse Full Press Release of This Report:- http://www.transparencymarketresearch.com/pressrelease/computer-aided-detection-market.htm

Medical Transcription Services Market is Expected to Reach USD 60.6 Billion Globally in 2019

According to a new market report published by Transparency Market Research “Medical Transcription Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, the global medical transcription services market was valued at USD 41.4 billion in 2012 and is expected to grow at a CAGR of 5.6% from 2013 to 2019, to reach an estimated value of USD 60.6 billion in 2019.

Medical transcription (MT) is one of the application based domains of healthcare management and is currently facing intense transformation. Factors such as infrastructural initiatives taken up by governments, implementation of electronic health record systems in developed nations, automation of healthcare operations and growing concerns for offering better, safe and swift healthcare service to the patients will have an impact on the current model of medical transcription industry.

We are currently offering a flat 15% discount on all purchases until end of the March 2015:- http://www.transparencymarketresearch.com/medical-transcription-services.html

The global medical transcription is segmented on the basis of service types and by the mode of procurement of transcription services. Based on service type, the medical transcription services is classified into History and Physical Report (H&P), Discharge Summary (DS), Operative Note or Report (OP), Consultation Report (CONSULTS), Others (Pathology Report (PATH) & Radiology Report (x rays or radiographs)) market. The market share of CONSULT reports is largest among all the other reports in the medical transcription services market as these reports are repeatedly produced for single patients undergoing treatment each time the patient visits the specialist. It is expected that the global market fort CONSULT reports will reach USD 21.1 billion with the market growing at a CAGR of 3.3% from 2013 to 2019. Earlier H&P reports were made only for hospitalized patients and patients undergoing treatment which involved several visits to specific clinics or hospitals but currently H&P reports are made for both inpatients as well as outpatients to reduce the risk of reimbursement issues. This has increased the share of H&P reports in the overall medical transcription services market.

Any healthcare institute in order to acquire medical transcription service can either outsource the job to a domestic medical transcription service organization, offshore or opt for both methods. Outsourcing is the most preferred mode of service procurement in medical transcription with the market share of 62.2% in 2012. In addition, large internationally operating healthcare organizations prefer to opt for both the modes of service procurement, due to reasons such as ease of operations, rapid turnaround times and easy allocation of monetary resources on the basis of nature of reports.

Asian countries such as India and Philippines are some of the leading hubs for offshoring of transcription services. Most of the offshored business is captured by these countries and is supported by government incentives and subsidies for setting new business and expansion of existing business units. United Arab Emirates (UAE) and Latin America are emerging markets in RoW followed by Qatar. North America currently dominates and is expected to retain its position in the medical transcription services market in the future. Growth drivers for this market in North America are factors such as rise in aging population and passing of Patient Protection and Affordable Healthcare Act, 2013. The North America medical transcription services market was worth more than USD 18 billion and is expected to grow at a CAGR of over 5% in the forecast period.

The global medical transcription services market is highly competitive in nature with a large number of market consolidation activities being conducted in the past ten years. Some of the key market players operating in this market include Acusis LLC, Nuance Communications,Inc., MModal, Inc., iMedX Information Services Pvt. Ltd, Precyse Solutions LLC, Scribe Healthcare Technologies, Inc., Superior Global Solutions, Inc., Transcend Services, Inc. and TransTech Medical Solutions.

Get Sample Report Copy with TOC and Market Research :- http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1662

The global medical transcription services market is segmented as follows:

Medical Transcription Services Market, by Service Type

• History and Physical Report (H&P)
• Discharge Summary (DS)
• Operative Note or Report (OP)
• Consultation Report (CONSULTS)
• Others (Pathology Report (PATH) & Radiology Report (X-rays or radiographs))

Medical Transcription Services Market, by Mode of Procurement

• Outsourcing
• Offshoring
• Both

Medical Transcription Services Market, by Geography

• North America
• Europe
• Asia Pacific
• Rest of the World (RoW)

Browse Full Press Release of This Report:- http://www.transparencymarketresearch.com/pressrelease/medical-transcription-services-market.htm

Browse Full Article of This Report:- http://www.transparencymarketresearch.com/article/medical-transcription-services.htm

Hospital Infection Therapeutics Market Expected to Reach USD 3.62 Billion Globally in 2020

According to a new market report published by Transparency Market Research “Hospital Infection Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020” the hospital infection therapeutics market was valued at USD 3.06 billion in 2013 and is expected to grow at a CAGR of 3.1% from 2014 to 2020, to reach an estimated value of USD 3.62 billion in 2020.

Hospital infections, commonly known as hospital-acquired infections (HAIs) or nosocomial infections, are referred to infections that develop in patients undergoing treatment in a healthcare setting such as hospitals, nursing homes, outpatient surgery centers, dialysis centers and rehabilitation centers. According to the World Health Organization (WHO), hospital infections are those infections that occur within 48 hours of hospitalization or after 72 hours of discharge from hospitals or within 30 days after treatment. Hospital infections mostly originate in intensive care units (ICUs) of a hospital compared to other divisions. According to the Centers for Disease Control and Prevention (CDC), more than 1.7 million hospital infections from different pathogenic microorganisms combined have been reported in 2011, in the U.S. CDC also estimated that hospital infections accounted for 99,000 deaths in the U.S. in the year 2011.

We are currently offering a flat 15% discount on all purchases until end of the March 2015:-

http://www.transparencymarketresearch.com/hospital-infection-therapeutics.html

Major hospital infection therapeutics that are available in the global market has been categorized into three major drug segments, namely, antibacterial, antiviral and antifungal drugs. Some of the major types of hospital infections include hospital-acquired pneumonia, urinary tract infections, gastrointestinal disorders, bloodstream infections, surgical site infections and other hospital infections. Major driving factors for the growth of the hospital infection therapeutics market include increasing prevalence of various hospital infections, aging population, increasing healthcare awareness and demand for improved therapeutic drugs. However, increasing multi-drug resistance that has rendered many drugs obsolete and increasing number of surveillance and infection control programs, such as, point prevalence survey by ECDC, Europe and HAI prevalence survey by CDC, U.S., may restrain the growth of this market. But, increasing multi-drug resistance and demand for improved infection treatment drugs have induced various drug developers and manufacturers to develop advanced therapeutic drugs. Several drugs that are in their phase III clinical trials will soon be commercialized during the forecast period and will add to the growth of this market in future. Some of the major drugs that are in their late stage clinical trials are Ceftolozane/Tazobactam, Dalvance, Delafloxacin, MK-3415A, Surotomycin, Eravacycline, and Tedizolid among others.

North America dominates the global hospital infection therapeutics market, in terms of revenue, followed by the European market in 2013. Major factors responsible for the leading position of the North American market are high prevalence of various hospital infections, rising number of multidrug-resistant microbial pathogens, and increasing demand for advanced therapeutics. High awareness level along with high purchasing capacity of the people is also contributing to the growth of the market in the region. Rising geriatric population in North America and Europe will add to the population of affected patients with hospital infections as aged patients exhibit lowered immunity levels. Thus, the increase in affected patient population will require increased use of various therapeutic drugs, which in turn will contribute towards the growth of this market. Asia-Pacific is expected to show the highest rate of growth in the global hospital infection therapeutics market during the forecast period 2014 to 2020. Some of the major factors responsible for high growth rate are rapidly increasing prevalence of hospital-acquired infections in the region, rising awareness and demand for new and improved hospital infection treatment drugs, and increasing healthcare infrastructure as well as purchasing power of people in the region.

Actavis plc, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Cubist Pharmaceuticals, Inc., GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer, Inc., and Sanofi are some of the major players operating in the global hospital infection therapeutics market.

Get Sample Report Copy with TOC and Market Research :- http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1280

See More Articles :- https://www.linkedin.com/today/author/349336221

The global hospital infection therapeutics market is segmented as follows:

Hospital Infection Therapeutics Market, by Drug Type

• Antibacterial Drugs
• Antiviral Drugs
• Antifungal Drugs

Hospital Infection Therapeutics Market, by Major Infections

• Hospital-Acquired Pneumonia
• Surgical Site Infections
• Urinary Tract Infections
• Gastrointestinal Disorders
• Bloodstream Infections
• Other Hospital Infections

Hospital Infection Therapeutics Market, by Geography

• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Browse Full Press Release of This Report:- http://www.transparencymarketresearch.com/pressrelease/hospital-infection-therapeutics.htm